Estimated annual percentage change (RR-1)% in incidence for physician reported and recognised compensation cases, 95% CIs from 2001 to 2010
| Country | Contact dermatitis | Allergic Contact dermatitis | Irritant Contact dermatitis | Asthma | Noise-induced hearing loss | Carpal tunnel syndrome | Upper limb musculoskeletal disorders |
|---|---|---|---|---|---|---|---|
| Physician-reported—annual % change 95% CI | |||||||
| France (RNV3P) | 0.1 −0.9 to 1.1 | 1.8 0.6 to 3.0 | −3.1 −4.6 to −1.6 | −14.8 −16.1 to −13.5 | −2.1 −3.8 to −0.5 | −1.4 −3.1 to 0.2 | 14.7 12.9 to 16.5 |
| Italy | −8.4 −10.5 to −6.4 | – | – | −3.7 −6.0 to −1.3 | −5.9 −7.9 to −3.9 | 7.1 3.9 to 10.5 | 13.9 5.9 to 22.6 |
| The Netherlands (clinical specialist) | −10.8 −13.3 to −8.3 | – | – | −9.1 −19.0 to 2.1 | – | – | – |
| The Netherlands (OP) | −0.3 −2.4 to 1.8 | − | − | −0.8 −5.6 to 4.3 | 3.0 1.0 to 5.0 | 0.6 −2.8 to 4.2 | −3.4 −4.4 to −2.4 |
| The UK (clinical specialist) | −3.0 −4.0 to −1.8 | −6.3 −7.9 to −4.7 | −0.2 −1.7 to 1.4 | −9.1 −11.2 to −5.9 | – | – | – |
| The UK (OP) | −6.7 −9.9 to −3.5 | – | – | −11.9 −17.6 to −5.8 | – | −4.3 −10.5 to 2.2 | −6.2 −8.4 to −4.0 |
| Recognised compensation—annual % change 95% CI (annual mean number of cases) | |||||||
| Belgium | – | – | – | – | 1.5 −0.8 to 3.9 | 1.2 −2.8 to 5.4 | – |
| Czech Republic | −4.8 −8.0 to −1.5 | −8.1 −10.1 to −6.0 | −1.1 −5.4 to 3.5 | −1.7 −5.6 to 2.4 | −1.1 −5.0 to 2.9 | 4.7 (2.3 to 7.0) | 4.5 1.5 to 7.6 |
| Italy | −10.5 −11.6 to −9.4 | – | – | −3.8 −6.1 to −1.5 | −1.8 −3.3 to −0.3 | – | 19.0 16.7 to 21.5 |
| Spain | – | – | – | −3.1 −9.5 to 3.7 | 9.5 2.1 to 17.4 | 1.8 −1.3 to 5.0 | – |
| Switzerland | −6.0 −6.7 to −5.3 | −6.1 −7.5 to −4.7 | −6.5 −8.2 to −4.6 | −3.2 −5.1 to −1.3 | 4.7 2.9 to 6.6 | – | −11.6 −12.7 to −10.6 |
| Great Britain (UK data NA) | −12.5 −15.2 to −9.8 | – | – | −3.7 −7.4 to 0.3 | −6.0 −8.3 to −3.2 | −7.9 −11.5 to −4.1 | – |
NA, not applicable; RR, rate ratio.